These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29957252)

  • 1. Patient reported outcome in HFpEF: Sex-specific differences in quality of life and association with outcome.
    Faxén UL; Hage C; Donal E; Daubert JC; Linde C; Lund LH
    Int J Cardiol; 2018 Sep; 267():128-132. PubMed ID: 29957252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life questionnaire predicts poor exercise capacity only in HFpEF and not in HFrEF.
    Ahmeti A; Henein MY; Ibrahimi P; Elezi S; Haliti E; Poniku A; Batalli A; Bajraktari G
    BMC Cardiovasc Disord; 2017 Oct; 17(1):268. PubMed ID: 29041912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing health-related quality of life in heart failure patients attending an outpatient clinic: a pragmatic approach.
    Gallagher AM; Lucas R; Cowie MR
    ESC Heart Fail; 2019 Feb; 6(1):3-9. PubMed ID: 30311454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity.
    Reddy YNV; Rikhi A; Obokata M; Shah SJ; Lewis GD; AbouEzzedine OF; Dunlay S; McNulty S; Chakraborty H; Stevenson LW; Redfield MM; Borlaug BA
    Eur J Heart Fail; 2020 Jun; 22(6):1009-1018. PubMed ID: 32150314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction.
    Yang M; Kondo T; Talebi A; Jhund PS; Docherty KF; Claggett BL; Vaduganathan M; Bachus E; Hernandez AF; Lam CSP; Inzucchi SE; Martinez FA; de Boer RA; Kosiborod MN; Desai AS; Køber L; Ponikowski P; Sabatine MS; Solomon SD; McMurray JJV
    Eur J Heart Fail; 2024 Jul; 26(7):1524-1538. PubMed ID: 38700986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
    Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
    Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Kansas City Cardiomyopathy Questionnaire and Minnesota Living With Heart Failure Questionnaire in Predicting Heart Failure Outcomes.
    Yee D; Novak E; Platts A; Nassif ME; LaRue SJ; Vader JM
    Am J Cardiol; 2019 Mar; 123(5):807-812. PubMed ID: 30587373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Measures to Assess Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction.
    Napier R; McNulty SE; Eton DT; Redfield MM; AbouEzzeddine O; Dunlay SM
    JACC Heart Fail; 2018 Jul; 6(7):552-560. PubMed ID: 29885952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of diabetes and sex in heart failure with reduced ejection fraction patients from the ASIAN-HF registry.
    Chandramouli C; Teng TK; Tay WT; Yap J; MacDonald MR; Tromp J; Yan L; Siswanto B; Reyes EB; Ngarmukos T; Yu CM; Hung CL; Anand I; Richards AM; Ling LH; Regensteiner JG; Lam CSP;
    Eur J Heart Fail; 2019 Mar; 21(3):297-307. PubMed ID: 30548089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical relevance of quality of life in heart failure patients with preserved ejection fraction.
    Seo M; Watanabe T; Yamada T; Yano M; Hayashi T; Nakagawa A; Nakagawa Y; Tamaki S; Yasumura Y; Sotomi Y; Hikoso S; Nakatani D; Fukunami M; Sakata Y;
    ESC Heart Fail; 2023 Apr; 10(2):995-1002. PubMed ID: 36510693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and outcomes in heart failure patients with ejection fractions in different ranges.
    Chen X; Xin Y; Hu W; Zhao Y; Zhang Z; Zhou Y
    PLoS One; 2019; 14(6):e0218983. PubMed ID: 31247042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life and chronic heart failure therapy guided by natriuretic peptides: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study.
    Bhardwaj A; Rehman SU; Mohammed AA; Gaggin HK; Barajas L; Barajas J; Moore SA; Sullivan D; Januzzi JL
    Am Heart J; 2012 Nov; 164(5):793-799.e1. PubMed ID: 23137512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life.
    Bekfani T; Pellicori P; Morris D; Ebner N; Valentova M; Sandek A; Doehner W; Cleland JG; Lainscak M; Schulze PC; Anker SD; von Haehling S
    Clin Res Cardiol; 2019 Feb; 108(2):203-211. PubMed ID: 30051186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnic differences in quality of life and its association with survival in patients with heart failure.
    Stein G; Teng TK; Tay WT; Richards AM; Doughty R; Dong Y; Sim D; Yeo PSD; Jaufeerally F; Leong G; Soon D; Ling LH; Lam CSP
    Clin Cardiol; 2020 Sep; 43(9):976-985. PubMed ID: 32562317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex Differences in Exercise Capacity and Quality of Life in Heart Failure With Preserved Ejection Fraction: A Secondary Analysis of the RELAX and NEAT-HFpEF Trials.
    Honigberg MC; Lau ES; Jones AD; Coles A; Redfield MM; Lewis GD; Givertz MM
    J Card Fail; 2020 Mar; 26(3):276-280. PubMed ID: 31945458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
    Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices.
    Snipelisky D; Kelly J; Levine JA; Koepp GA; Anstrom KJ; McNulty SE; Zakeri R; Felker GM; Hernandez AF; Braunwald E; Redfield MM
    Circ Heart Fail; 2017 Jun; 10(6):e003878. PubMed ID: 28588021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life.
    Bekfani T; Pellicori P; Morris DA; Ebner N; Valentova M; Steinbeck L; Wachter R; Elsner S; Sliziuk V; Schefold JC; Sandek A; Doehner W; Cleland JG; Lainscak M; Anker SD; von Haehling S
    Int J Cardiol; 2016 Nov; 222():41-46. PubMed ID: 27454614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
    Black-Maier E; Ren X; Steinberg BA; Green CL; Barnett AS; Rosa NS; Al-Khatib SM; Atwater BD; Daubert JP; Frazier-Mills C; Grant AO; Hegland DD; Jackson KP; Jackson LR; Koontz JI; Lewis RK; Sun AY; Thomas KL; Bahnson TD; Piccini JP
    Heart Rhythm; 2018 May; 15(5):651-657. PubMed ID: 29222043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.